Ipragliflozin ameliorates liver damage in non-alcoholic fatty liver disease

Miyake, T; Yoshida, S; Furukawa, S; Sakai, T; Tada, F; Senba, H; Yamamoto, S; Koizumi, Y; Yoshida, O; Hirooka, M; Kumagi, T; Niiya, T; Miyaoka, H; Masanori, A; Matsuura, B; Hiasa, Y

Miyake, T (reprint author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime 7910295, Japan.

OPEN MEDICINE, 2018; 13 (1): 402

Abstract

Background: There are few effective medications for non-alcoholic steatohepatitis (NASH). We investigated the efficacy of ipragliflozin (selective sod......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索